MyleA.00213.a: Putative enoyl-CoA hydratase
Target Characteristics
| from organism: | Mycobacterium leprae Br4923 |
| most recent status: | selected |
| center reference id: | MyleA.00213.a |
| is community request: | False |
| associated disease: | Hansen's disease, leprosy |
| NIH risk group: | 2 |
| is select agent: | False |
| NIH priority pathogens category: |
IIIC |
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
External Resources
| Resource | Reference ID |
|---|---|
| OrthoMCL: | OG5_129459 |
| PATRIC ID: | fig|561304.4.peg.181 |
| RefSeq: | YP_002502847.1 |
| UniProt: | A0A0H3MP13 |
Enzyme & Pathway Information
| Pathway | Pathway ID | EC Number |
|---|---|---|
| fatty acid beta-oxidation I | FAO-PWY | 4.2.1.17 |
| L-isoleucine degradation I | ILEUDEG-PWY | 4.2.1.17 |
| oleate beta-oxidation | PWY0-1337 | 4.2.1.17 |
| phenylacetate degradation I (aerobic) | PWY0-321 | 4.2.1.17 |
| benzoyl-CoA degradation I (aerobic) | PWY-1361 | 4.2.1.17 |
| fermentation to 2-methylbutanoate | PWY-5109 | 4.2.1.17 |
| fatty acid beta-oxidation II (peroxisome) | PWY-5136 | 4.2.1.17 |
| unsaturated, even numbered fatty acid beta-oxidation | PWY-5138 | 4.2.1.17 |
| superpathway of glyoxylate cycle and fatty acid degradation | PWY-561 | 4.2.1.17 |
| superpathway of phenylethylamine degradation | PWY-6071 | 4.2.1.17 |
| 4-hydroxybenzoate biosynthesis III (plants) | PWY-6435 | 4.2.1.17 |
| fatty acid beta-oxidation VI (peroxisome) | PWY66-391 | 4.2.1.17 |
| pyruvate fermentation to hexanol (engineered) | PWY-6863 | 4.2.1.17 |
| superpathway of cholesterol degradation I (cholesterol oxidase) | PWY-6928 | 4.2.1.17 |
| superpathway of testosterone and androsterone degradation | PWY-6937 | 4.2.1.17 |
| androstenedione degradation | PWY-6944 | 4.2.1.17 |
| superpathway of cholesterol degradation II (cholesterol dehydrogenase) | PWY-6947 | 4.2.1.17 |
| methyl ketone biosynthesis (engineered) | PWY-7007 | 4.2.1.17 |
| 4-coumarate degradation (anaerobic) | PWY-7046 | 4.2.1.17 |
| fatty acid salvage | PWY-7094 | 4.2.1.17 |
| jasmonic acid biosynthesis | PWY-735 | 4.2.1.17 |
| docosahexaenoate biosynthesis III (6-desaturase, mammals) | PWY-7606 | 4.2.1.17 |
| (8E,10E)-dodeca-8,10-dienol biosynthesis | PWY-7654 | 4.2.1.17 |
| Spodoptera littoralis pheromone biosynthesis | PWY-7656 | 4.2.1.17 |
| (4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase) | PWY-7726 | 4.2.1.17 |
| toluene degradation to benzoyl-CoA (anaerobic) | PWY-81 | 4.2.1.17 |
| L-valine degradation I | VALDEG-PWY | 4.2.1.17 |
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MGSDINRAYE SVAVEIKDRV AQVTLIGPGK GNAMGPAFWS EMPEVFAELD TNREVRAVVI TGSGKDFSYG LDVPAMGGKF VPLLTDGALA RPRTDFHAEV LRMQKAINAV ADCRTPTIAA VHGWCIGGAL DLISAVDIRY ASADAKFSMR EVKLAIVADM GSLARLPLIL SDGHLRELAL TGKDIDATRA EKIGLVNDVY DNADKTLAAA HATAAEIAAN PPLAVYGVKD VLYQQRTSAI SESLRYVAAW NAAFLPSKDL TEGISATFAK RAPQFIGE
NT Sequence
ATGGGCTCAG ACATAAATCG GGCATATGAA TCCGTTGCCG TCGAAATCAA AGATCGGGTT GCACAGGTAA CACTGATCGG GCCAGGCAAG GGCAACGCGA TGGGGCCGGC CTTCTGGTCG GAGATGCCGG AGGTGTTCGC AGAGCTAGAT ACCAACCGTG AGGTACGGGC CGTCGTCATC ACCGGATCAG GAAAAGATTT TAGCTACGGC CTGGACGTGC CCGCGATGGG CGGAAAGTTC GTCCCATTGC TGACCGACGG CGCACTGGCA CGCCCCCGCA CCGACTTCCA CGCCGAAGTG CTGCGGATGC AGAAGGCGAT AAACGCCGTC GCTGATTGCC GCACGCCCAC GATCGCGGCG GTGCACGGCT GGTGCATTGG TGGCGCTTTA GACCTGATCT CCGCGGTCGA TATCCGCTAC GCCAGCGCCG ACGCCAAGTT CTCAATGCGG GAAGTCAAAC TGGCCATAGT CGCCGACATG GGCAGTCTCG CCCGCCTTCC ACTGATCTTG AGCGACGGGC ATCTGCGTGA ACTGGCGTTG ACGGGAAAAG ACATCGACGC GACCCGCGCC GAGAAAATTG GCCTTGTAAA TGATGTCTAC GACAATGCCG ACAAGACGCT GGCTGCCGCC CATGCCACCG CTGCCGAGAT CGCCGCCAAC CCGCCACTAG CGGTCTACGG CGTCAAGGAT GTCCTTTACC AACAACGCAC CTCCGCGATC TCAGAGAGCC TACGCTACGT CGCTGCGTGG AACGCGGCCT TTCTGCCGTC CAAGGATCTG ACCGAGGGCA TATCGGCCAC GTTCGCCAAG CGGGCACCGC AGTTCATCGG GGAG